Although we did not find evidence for a classical neuroendocrine phenotype, recent studies have suggested a broader relevance for neuroendocrine differentiation with powerful transcription factors such as Myc and cell cycle regulators such as AURKA being implicated in development of therapy resistant tumours bearing neuroendocrine characteristics (Beltran et al, 2011). The gene discussed is MYC; the disease is neoplasm.